Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. F. Ou-Yang, C. G. Wu (Xi‘an, China). The role of bone-marrow derived adult stem cells in asthmatic airway remodeling. Eur Respir J 2011; 38: Suppl. 55, 3274

Member's Comments

No comment yet.

Related content which might interest you: In vivo chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 The role of altered stem cell function in airway and alveolar repair and remodelling in COPD Source: Eur Respir Monogr 2021; 91: 322-339 Year: 2021 Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 The contribution of bone marrow derived progenitor cells to lung remodelling Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 The role of resident lung mesenchymal stromal cells in normal and aberrant lung development Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Late-breaking abstract: Comparison of bone marrow derived-mononuclear cells with mesenchymal stem cells on inflammatory and remodeling processes in experimental chronic allergic asthma Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease Year: 2011 Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma Source: Eur Respir J 2011; 38: 679-687 Year: 2011 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Monitoring of lung function and bronchial inflammation after bone marrow transplantation: preferential recruitment of lymphocytes into the airways Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair in vitro Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007